Maternal use of thyroid hormones in pregnancy and neonatal outcome

References

• Klein RZ, Haddow JE, Faix JD, Brown RS, Hermos RJ, Pulkkinen A, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol. 1991; 35: 41–6
   PubMed Web of Science ®Google Scholar
• Bjøro T, Holmen J, Krüger Ø, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trøndelag (HUNT). Eur J Endocrinol. 2000; 143: 639–47
   PubMed Web of Science ®Google Scholar
• Becks GP, Burrow GN. Thyroid disease and pregnancy. Med Clin North Am. 1991; 75: 121–50
   PubMed Web of Science ®Google Scholar
• Blazer S, Moreh-Waterman Y, Miller-Lotan R, Tamir A, Hochberg Z. Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol. 2003; 102: 232–41
   PubMed Web of Science ®Google Scholar
• Haddow JE, Palomake GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341: 549–55
   PubMed Web of Science ®Google Scholar
• Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004; 351: 241–9
   PubMed Web of Science ®Google Scholar
• Wolfberg A, Lee-Parritz A, Peller AJ, Lieberman E. Obstetric and neonatal outcomes associated with maternal hypothyroid disease. J Matern Fetal Neonatal Med. 2005; 17: 35–8
   PubMed Web of Science ®Google Scholar
• Idris I, Srinivasan R, Simm A, Page RC. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol. 2005; 63: 560–5
   PubMed Web of Science ®Google Scholar
• Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol. 2007; 66: 309–21
   PubMed Web of Science ®Google Scholar
• Poppe K, Glinoer D, Tounaye H, Devroey P, van Steirteghem A, Kaufman L, et al. Assisted reproduction and thyroid autoimmunity: an unfortunate combination?. J Clin Endocrinol Metab. 2003; 88: 4149–52
   PubMed Web of Science ®Google Scholar
• Tan TO, Cheng YW, Caughey AB. Are women who are treated for hypothyroidism at risk for pregnancy complications?. Am J Obstet Gynecol. ;:e 2006; 194: 1–3
   PubMed Web of Science ®Google Scholar
• Stagnaro-Green A, Chen X, Bogden JD, Davies TF, Scholl TO. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid. 2005; 15: 351–7
   PubMed Web of Science ®Google Scholar
• Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000; 7: 127–30
   PubMed Web of Science ®Google Scholar
• Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005; 105: 239–45
   PubMed Web of Science ®Google Scholar
• National Board of Health and Welfare. Centre for Epidemiology. The Swedish Medical Birth Register – a summary of content and quality. Available online at, , http://www.sos.se/FULLTEXT/112/2003-112-3/2003-112-3.pdf. (accessed 15 October 2007).
   Google Scholar
• The National Board of Health and Welfare. Centre for Epidemiology. Research Report from EpC (2004). Registration of congenital malformations in the Swedish health registers. Available online at, , http://www.socialstyrelsen.se/Publicerat/2004/5120/2004–112-1.htm. (accessed 15 October 2007).
   Google Scholar
• Källén B. A birth weight for gestational age standard based on data in the Swedish Medical Birth Registry, –1989. Eur J Epidemiol. :11 1985; 1995: 601–6
   Google Scholar
• Miettinen OS. Simple interval estimation of risk ratio. Am J Epidemiol. 1974; 100: 515–6
   Web of Science ®Google Scholar
• Alvarez-Marfany M, Roman SH, Drexler AJ, Robertson C, Stagnaro-Green A. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 1994; 79: 10–6
   PubMed Web of Science ®Google Scholar
• Olivieri A, Valensise H, Magnani F, Medda E, De Angelis S, D'Archivio M, et al. High frequency of antithyroid autoantibodies in pregnant women at increased risk of gestational diabetes mellitus. Eur J Endocrinol. 2000; 143: 741–7
   PubMed Web of Science ®Google Scholar
• Lapaire O, Hösli I, Zanetti-Daellenbach R, Huang D, Jaeggi C, Gatfield-Mergenthaler S, et al. Impact of fetal-maternal microchimerism on women's health – a review. J Matern Fetal Neonatal Med. 2007; 20: 1–5
   PubMed Web of Science ®Google Scholar
• Bülow Pedersen I, Laurberg P, Knudsen N, Jørgensen T, Perrild H, Ovesen L, et al. Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity. Eur J Endocrinol. 2006; 154: 39–45
   PubMed Web of Science ®Google Scholar
• Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA. 2004; 292: 691–5
   PubMed Web of Science ®Google Scholar
• Källén B, Finnström O, Nygren KG, Otterblad Olausson P. In vitro fertilization in Sweden: maternal characteristics. Acta Obstet Gynecol Scand. 2005; 84: 1185–91
   PubMed Web of Science ®Google Scholar
• Papadopoulos K, Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiophatic Addison's disease. Acta Endocrinol (Copenh) 1990; 122: 472–8
   PubMedGoogle Scholar
• Pop VJ, Wijnen HA, Lapkienne L, Bunivicius R, Vader HL, Essed GG. The relation between gestational thyroid parameters and depression: a reflection of the downregulation of the immune system during pregnancy?. Thyroid. 2006; 16: 485–92
   PubMed Web of Science ®Google Scholar
• Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol. 2007; 63: 363–73
   PubMed Web of Science ®Google Scholar
• Peleg D, Cada S, Peleg A, Ben-Ami M. The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol. 2002; 99: 1040–3
   PubMed Web of Science ®Google Scholar
• Källén BAJ, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol. 2003; 17: 255–61
   PubMed Web of Science ®Google Scholar
• Robert E, Vollset SE, Botto L, Lancaster PAL, Merlob P, Mastroiacovo P, et al. Malformation surveillance and maternal drug exposure: the MADRE project. Int J Risk Safety Med. 1994; 6: 75–118
   PubMedGoogle Scholar